Skip to main content
Kompella Technologies

Boston, Massachusetts · From $8,000/month

Fractional CTO in Boston

Biotech-grade engineering rigor and FDA-aware product strategy for Boston and Cambridge startups born out of MIT, Harvard, and the Longwood Medical Area.

A fractional CTO in Boston provides senior technology leadership 1–3 days per week for biotech, healthtech, regulated industries, and edtech startups. Engagements run $8,000–$25,000 per month — roughly 30–50% the all-in cost of a full-time CTO hire. Biotech-grade engineering rigor and FDA-aware product strategy for Boston and Cambridge startups born out of MIT, Harvard, and the Longwood Medical Area. Most Boston engagements start within 2 weeks and operate on the Eastern (UTC-5) timezone with USD billing available.

The Boston Ecosystem

Why a fractional CTO works for Boston startups.

Boston's startup ecosystem is built on regulation, research, and resident talent — not VC FOMO. The Cambridge biotech corridor (Moderna, Vertex, Ginkgo Bioworks, Foundation Medicine) and the Longwood Medical Area give the city the deepest healthcare and life sciences density in the country. That regulated-industry DNA shapes every layer of the local tech ecosystem: founders have a higher tolerance for rigor, longer time horizons, and a working understanding of FDA pathways, HIPAA, and clinical evidence standards. The talent pipeline is also genuinely different from other US cities. MIT and Harvard graduate cohorts, Northeastern co-ops, and the broader academic ecosystem produce engineering and product talent with deeper formal training than coastal averages. Companies like HubSpot, Toast, Wayfair, athenahealth, and DraftKings have built strong engineering cultures here that mid-tier startups can recruit from. For a fractional CTO engagement, Boston creates a specific opportunity and constraint. The opportunity: founders here often need help bridging deep technical or scientific founders with commercial product velocity. The constraint: regulated-industry timelines mean engagements usually run longer (12–18 months instead of 6–12) and the work skews toward architecture, compliance, and team building rather than pure go-to-market velocity. The verticals where fractional CTO leadership creates the most leverage: digital health and SaMD pathways, healthtech selling to integrated delivery networks, edtech tied to higher ed, climate tech (the local cleantech corridor is rebuilding), and any company whose technical risk maps to FDA, HIPAA, or HITRUST compliance.

Local Context

Pattern-matched for biotech, healthtech, regulated industries, and edtech.

Boston engineering talent often comes through Moderna, Vertex Pharmaceuticals, Ginkgo Bioworks, athenahealth, and the founder market expects fractional leadership that has shipped at that bar. We have.

What You Get

Same playbook as our service page — applied to Boston startups.

Technical Architecture & Strategy

We choose your stack, design your system architecture, and define the infrastructure strategy that maps to your next 18 months of business outcomes — not the next quarter's hype cycle.

Engineering Team Building

We write the JD, run the technical loop, calibrate the bar, and close strong candidates. We've hired engineers from staff to senior, in the US, India, and EU.

Product & Roadmap Ownership

We translate business goals into a technical roadmap with concrete trade-offs: what we build now, what we defer, what we kill. Engineering knows what to ship next.

AI & Automation Strategy

We identify where AI creates real leverage versus where it's a feature for the deck. Model selection, evaluation, MLOps, and the build-vs-buy line.

Vendor & Build-vs-Buy Decisions

We evaluate platforms, tools, and outsourcing partners against your stage and trajectory. Build only what differentiates; buy everything else.

Board & Investor Communication

We prepare technology updates for board meetings, lead due-diligence sessions during fundraises, and translate engineering reality into language investors trust.

Pricing in Boston

Three transparent tiers — billed in USD.

Advisory

$8,000 / month

1 day/week

Strategic guidance, architecture review, board prep, hiring calibration. No day-to-day ownership.

Ideal stage

Pre-seed founders, post-launch teams with a junior CTO

Fractional

$15,000 / month

2 days/week

Embedded leadership: roadmap ownership, hiring, code/architecture decisions, board updates.

Ideal stage

Seed–Series A startups; growth-stage teams scaling engineering

Embedded

$25,000 / month

3+ days/week

Near-full-time CTO involvement. Major migrations, IPO prep, building from scratch, or replacing a departed CTO.

Ideal stage

Series A/B in critical phases; PE-backed portfolio companies

FAQ

Boston-specific questions.

Yes. We've supported product strategy and architecture for SaMD-adjacent platforms and HIPAA-covered systems (Aesthetic Record, Life Imaging, A'alda). For pure software-as-medical-device clearance work, we partner with regulatory consultants — we own the engineering posture, they own the FDA submission.
Yes. Most Boston engagements include 1–2 days per month in person, typically in Kendall Square, the Seaport, or downtown. For embedded-tier engagements we can structure higher in-person cadence. Eastern timezone makes our overlap with European and Indian teams natural.
Many Boston founders are PhDs or MD-PhDs whose technical depth is real and whose commercial product muscle is still developing. We translate engineering and product trade-offs into language that respects their depth — we don't dumb things down, we structure them. The deliverable is a roadmap and team they can defend to a board, not a deck.
Yes. HIPAA is core to our healthcare work. We've shipped HIPAA-covered platforms across multiple engagements; we run security and compliance reviews as a standard part of every healthcare engagement; and we've supported HITRUST-readiness work for clients selling into integrated delivery networks. We're not a SOC 2 / HITRUST audit firm — we work alongside one.

Building something in Boston? Let's talk.

30 minutes. Three specific recommendations. No deck, no pitch — just judgment from someone who's shipped 75+ products across biotech, healthtech, regulated industries, and edtech.

Book a Free 30-Min Strategy Call →